The retinoblastoma-histone deacetylase 3 complex inhibits PPARγ and adipocyte differentiation

Developmental Cell

Volumn 3, Issue 6, 2002, Pages 903-910

  Fajas, Lluis ^a,d   Egler, Viviane ^a,c   Reiter, Raphael ^a,c   Hansen, Jacob ^b   Kristiansen, Karsten ^b   Debril, Marie Bernard ^a   Mirard, Stéphanie ^a   Auwerx, Johan ^a  

^a INSTITUT DE GÉNÉTIQUE ET DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

^b UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^c INSTITUT CLINIQUE DE LA SOURIS   (France)

^d Endocrinol Mol et Cellul Cancers   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN; CELL NUCLEUS RECEPTOR; HISTONE DEACETYLASE; HYBRID PROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; RETINOBLASTOMA PROTEIN; ROSIGLITAZONE;

ADIPOCYTE; ANIMAL CELL; ARTICLE; CELL CYCLE; CELL DIFFERENTIATION; COMPLEX FORMATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; GENE EXPRESSION; IMMUNOPRECIPITATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; TRANSACTIVATION;

ANIMALIA;

EID: 0036900873     PISSN: 15345807     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1534-5807(02)00360-X     Document Type: Article

References (30)

1. Beckstead, R., Ortiz, J.A., Sanchez, C., Prokopenko, S.N., Chambon, P., Losson, R., and Bellen, H.J. (2001). Bonus, a Drosophila homolog of TIF1 proteins, interacts with nuclear receptors and can inhibit betaFTZ-F1-dependent transcription. Mol. Cell 7, 753-765.
2. Brehm, A., Miska, E.A., McCance, D.J., Reid, J.L., Bannister, A.J., and Kouzarides, T. (1998). Retinoblastoma protein recruits histone deacetylase to repress transcription. Nature 391, 597-601.
3. Cavailles, V., Dauvois, S., L'Horset, F., Lopez, G., Hoare, S., Kushner, P.J., and Parker, M.G. (1995). Nuclear factor RIP140 modulates transcriptional activation by the estrogen receptor. EMBO J. 14, 3741-3751.
4. Chen, P., Riley, D.J., Chen, Y., and Lee, W. (1996a). Retinoblastoma protein positively regulates terminal adipocyte differentiation through direct interaction with C/EBPs. Genes Dev. 10, 2794-2804.
5. Chen, P.L., Riley, D.J., Chen, Y., and Lee, W.H. (1996b). Retinoblastoma protein positively regulates terminal adipocyte differentiation through direct interaction with C/EBPs. Genes Dev. 10, 2794-2804.
6. Choi, H., Lee, J., Park, J., and Lee, Y. (2002). Trichostatin A, a histone deacetylase inhibitor, activates the IGFBP-3 promoter by upregulating Sp1 activity in hepatoma cells: alteration of the Sp1/Sp3/HDAC1 multiprotein complex. Biochem. Biophys. Res. Commun. 296, 1005.
7. Classon, M., Kennedy, B.K., Mulloy, R., and Harlow, E. (2000). Opposing roles of pRB and p107 in adipocyte differentiation. Proc. Natl. Acad. Sci. USA 97, 10826-10831.
8. Fajas, L., Debril, M.B., and Auwerx, J. (2001). Peroxisome proliferator-activated receptor-gamma: from adipogenesis to carcinogenesis. J. Mol. Endocrinol. 27, 1-9.
9. Fajas, L., Landsberg, R.L., Huss-Garcia, Y., Sardet, C., Lees, J.A., and Auwerx, J. (2002). E2Fs regulate adipogenesis. Dev. Cell 3, 39-49.
10. Fajas, L., Paul, C., Zugasti, O., Le Cam, L., Polanowska, J., Fabbrizio, E., Medema, R., Vignais, M.L., and Sardet, C. (2000). pRB binds to and modulates the transrepressing activity of the E1A-regulated transcription factor p120E4F. Proc. Natl. Acad. Sci. USA 97, 7738-7743.
11. Guenther, M.G., Barak, O., and Lazar, M.A. (2001). The SMRT and N-CoR corepressors are activating cofactors for histone deacetylase 3. Mol. Cell. Biol. 21, 6091-6101.
12. Hansen, J.B., Petersen, R.K., Larsen, B.M., Bartkova, J., Alsner, J., and Kristiansen, K. (1999). Activation of peroxisome proliferator activated receptor γ bypasses the function of the retinoblastoma protein in adipocyte differentiation. J. Biol. Chem. 274, 2386-2393.
13. Higgins, C., Chatterjee, S., and Cherington, V. (1996). The block of adipocyte differentiation by a C-terminally truncated, but not by fulllength, simian virus 40 large tumor antigen is dependent on an intact retinoblastoma susceptibility protein family binding domain. J. Virol. 70, 745-752.
14. Johansson, L., Thomsen, J.S., Damdimopoulos, A.E., Spyrou, G., Gustafsson, J.A., and Treuter, E. (1999). The orphan nuclear receptor SHP inhibits agonist-dependent transcriptional activity of estrogen receptors ERalpha and ERbeta. J. Biol. Chem. 274, 345-353.
15. Lampen, A., Carlberg, C., and Nau, H. (2001). Peroxisome proliferator-activated receptor delta is a specific sensor for teratogenic valproic acid derivatives. Eur. J. Pharmacol. 431, 25-33.
16. Li, J., Lin, Q., Wang, W., Wade, P., and Wong, J. (2002). Specific targeting and constitutive association of histone deacetylase complexes during transcriptional repression. Genes Dev. 16, 687-692.
17. Magnaghi-Jaulin, L., Groisman, R., Naguibneva, I., Robin, P., Lorain, S., Le Villain, J.P., Troalen, F., Trouche, D., and Harel-Bellan, A. (1998). Retinoblastoma protein represses transcription by recruiting a histone deacetylase. Nature 391, 601-605.
18. Mazumdar, A., Wang, R.A., Mishra, S.K., Adam, L., Bagheri-Yarmand, R., Mandal, M., Vadlamudi, R.K., and Kumar, R. (2001). Transcriptional repression of oestrogen receptor by metastasis-associated protein 1 corepressor. Nat. Cell Biol. 3, 30-37.
19. Nagy, L., Kao, H.K., Chakravarti, D., Lin, R.J., Hassig, C.A., Ayer, D.E., Schreiber, S.L., and Evans, R.M. (1997). Nuclear receptor repression mediated by a complex containing SMRT, mSin3A, and histone deacetylase. Cell 89, 373-380.
20. Nikitin, A., Shan, B., Flesken-Nikitin, A., Chang, K.H., and Lee, W.H. (2001). The retinoblastoma gene regulates somatic growth during mouse development. Cancer Res. 61, 3110-3118.
21. Reichert, M., and Eick, D. (1999). Analysis of cell cycle arrest in adipocyte differentiation. Oncogene 18, 459-466.
22. Richon, V., Lyle, R.E., and McGehee, R.E.J. (1997). Regulation and expression of retinoblastoma proteins p107 and p130 during 3T3-L1 adipocyte differentiation. J. Biol. Chem. 272, 10117-10124.
23. Rocchi, S., Picard, F., Vamecq, J., Gelman, L., Potier, N., Zeyer, D., Dubuquoy, L., Bac, P., Champy, M.F., Plunket, K.D., et al. (2001). A unique PPARgamma ligand with potent insulin-sensitizing yet weak adipogenic activity. Mol. Cell 8, 737-747.
24. Rosen, E.D., Hsu, C.H., Wang, X., Sakai, S., Freeman, M.W., Gonzalez, F.J., and Spiegelman, B.M. (2002). C/EBPalpha induces adipogenesis through PPARgamma: a unified pathway. Genes Dev. 16, 22-26.
25. Rosenbaum, S.E., and Greenberg, A.S. (1998). The short- and long-term effects of tumor necrosis factor-alpha and BRL 49653 on peroxisome proliferator-activated receptor (PPAR)gamma2 gene expression and other adipocyte genes. Mol. Endocrinol. 12, 1150-1160.
26. Samid, D., Wells, M., Greene, M.E., Shen, W., Palmer, C.N., and Thibault, A. (2000). Peroxisome proliferator-activated receptor gamma as a novel target in cancer therapy: binding and activation by an aromatic fatty acid with clinical antitumor activity. Clin. Cancer Res. 6, 933-941.
27. Schoonjans, K., Peinado-Onsurbe, J., Lefebvre, A.M., Heyman, R., Briggs, M., Deeb, S., Staels, B., and Auwerx, J. (1996). PPARα and PPARγ activators direct a tissue-specific transcriptional response via a PPRE in the lipoprotein lipase gene. EMBO J. 15, 5336-5348.
28. Shao, D., and Lazar, M.A. (1997). Peroxisome proliferator activated receptor γ, CCAAT/enhancer binding protein α, and cell cycle status regulate the commitment to adipocyte differentiation. J. Biol. Chem. 272, 21473-21478.
29. Shi, Y., Downes, M., Xie, W., Kao, H.Y., Ordentlich, P., Tsai, C.C., Hon, M., and Evans, R.M. (2001). Sharp, an inducible cofactor that integrates nuclear receptor repression and activation. Genes Dev. 15, 1140-1151.
30. Treuter, E., Albrektsen, T., Johansson, L., Leers, J., and Gustafsson, J.A. (1998). A regulatory role for RIP140 in nuclear receptor activation. Mol. Endocrinol. 12, 864-881.